[의약품 회수·판매중지] 대우제약(주) 세라타제정(스트렙토키나제,스트렙토도르나제)
회수 사유: ‘스트렙토키나제·스트렙토도르나제’ 제제에 대한 재평가 결과, 유용성이 인정되지 않음 · 강제 회수(회수 명령) · 회수명령일자 2023-12-07 · 승인일자 2023-12-11
- Published by source
- 2023-12-07
- First seen by Reality Radar
- 2026-10-27
- Last verified
- 2026-10-27
Affected
- Manufacturer
- 대우제약(주)
- Products
- 세라타제정(스트렙토키나제,스트렙토도르나제)
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: 강제 회수(회수 명령): ‘스트렙토키나제·스트렙토도르나제’ 제제에 대한 재평가 결과, 유용성이 인정되지 않음
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- 식약처 의약품 회수·판매중지 (data.go.kr) Tier A · official published 2023-12-07
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #2047 | new | 2026-10-27 | 19b65c17e6ae…9251a6 | b43afa9f3789…e88839 |
Chain head: #2109 4575c5fcce85…11bda9